logo-loader
RNS
MedPal AI plc

Circular and Notice of General Meeting

RNS Number : 3737Y
Medpal AI PLC
09 October 2026
 

9 October 2026

MedPal AI plc

(“MedPal”, the “Company” or the “Group”)

Circular and Notice of General Meeting

 

Further to its announcement of 6 October 2026, MedPal AI plc (AIM: MPAL; FRA: Z1N), the AI-native digital health and pharmacy group, announces that a shareholder circular convening a General Meeting has been posted on the Company’s website at:

www.medpalplc.com/agm-and-gm-notices

The circular, together with a form of proxy, will shortly be sent to registered shareholders. The General Meeting has been convened for 10:00 a.m. on 29 October 2026 at the offices of Wedlake Bell LLP, 71 Queen Victoria Street, London, EC4V 4AY.

Proxy voting will be available from 5:00 p.m. today and instructions can be found in the circular.

EXPECTED TIMETABLE OF PRINCIPAL EVENTS

 

Time / Date

2026

Electronic publication of the circular by

10:00 a.m. on 9 October

 

Posting of Circular to Shareholders

9 October

Latest time and date for receipt of individual Forms of proxy / electronic proxy appointments

10:00 a.m. on  27 October

 

Record date for attendance at the General Meeting

6.00 p.m. on 27 October

General Meeting

10:00 a.m. on 29 October

Future times and dates are indicative only and are subject to change by the Company. If the expected timetable of events changes from the above, the Company will notify the Shareholders to this effect via Regulatory Information Service.

References to time in this announcement are to London times.

 

 

For further information please contact:

Enquiries:

MedPal AI plc

Jason Drummond, Chief Executive Officer

Via Square1 Consulting

Cairn Financial Advisers LLP (Nomad)

Louise O'Driscoll / Jo Turner

+44 (0) 20 7213 0880

Merlin Partners LLP (Broker)

 

+44 (0) 20 7839 3500

Clear Capital Markets Limited (Broker)

Bob Roberts

+44 (0) 20 3869 6080

Square1 Consulting – (Financial PR)

David Bick

+44 (0) 20 7929 5599 / +44 (0) 7831 381201

 

 

 

 

About MedPal AI plc

MedPal AI plc (AIM: MPAL; FRA: Z1N) is a vertically integrated, AI-native digital health and pharmacy group. The Group operates NHS Distance Selling Pharmacy hubs at Sarus Court, Runcorn and Swaffham, New Health (new.co.uk), a dedicated GLP-1 weight management clinic, a B2B care home pharmacy supply business, eMARx, the Group’s electronic medication administration record software for care homes, and Juno, an agentic AI health companion built on Anthropic’s Claude. MedPal’s ambition is to build the UK’s leading Health OS: a single platform connecting prescribing, dispensing, delivery, administration and AI-driven patient support. The Company’s LEI is 984500EDP8B0A14CBA61.

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOGUKVKRNVURRRA
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

3 min read